References
- Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Nature 1995; 373: 123–6.
- Wei X, Gosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117–9.
- Gougeon ML. Does apoptosis contribute to CD4 cell depletion in human immunodeficiency virus infection? Cell Death Differ 1995; 2: 1–13.
- Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV and SIV-infected lymph nodes. Nature Med 1995; 1: 29–34.
- Cohen JJ. Apoptosis: the physiologic pathway of cell death. Hosp Pract 1993; 28: 35–43.
- Groux H, Monte D, Bourrez JM, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4 T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175: 331–40.
- Lewis DE, Ng Tang DS, Adu-Oppong A, Schober W, Rodgers JR. Anergy and apoptosis in CD8 T cells from HIV infected persons. J Immunol 1994; 153: 412–20.
- Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO. The role of Apo-1-mediated apoptosis in the immune system. Immunol Rev 1994; 142: 175–90.
- Baumler CB, Bohler T, Herr I, Benner A, Krammer PH, Debatin KM. Activation of the CD95 (Apo-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 1996; 88: 1741–6.
- Lotem J, Sachs L. Regulation of bcl-2, bcl-XI and Bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 1995; 6: 647–53.
- Schwartz LM, Osborne BA. Programmed cell death apoptosis and killer genes. Immunol Today 1993; 14: 582–90.
- Centre for Disease Control. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43-RR-12: 1.
- Debatin KM, Fahrig-Faissnerr A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH. High expression of Apo-1 (CD95) on T-lymphocytes from human immunodeficiency virus infected children. Blood 1994; 83: 3101–7.
- Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 1995; 375: 497–500.
- Sastry KJ, Marin MC, Nehete PN, McConnell K, Elnaggar AK, McDonnell TJ. Expression of human immunodeficiency virus type 1 tat results in downregulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 1996; 13: 487–93.
- Lu PJ, Lu KL, Rughetti A, Taylor-Papadimitriu J. Bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol 1995; 129: 1363–78.
- Steller H. Mechanism and genes of cellular suicide. Science 1995; 267: 1445–9.
- Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–62.
- Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993; 178: 427–38.
- Strasser A, Harris AW, Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889–99.
- Akbar AN, Salmon M. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today 1997; 18: 72–5.
- Antonen J, Krohn K. Interleukin-2 production in HTLV-III/ LAV infection: evidence of defective antigen-induced, but normal mitogen-induced interleukin-2 production. Clin Exp Immunol 1986; 65: 489–96.
- Akbar AN, Borthwick NJ, Wickremasinghe RG. Interleukin2 receptor common gamma-chain signalling cytokines regulate activated T cell apoptosis in response for growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-XL) but not pro-apoptotic (Bax, BCL-XD) gene expression. Eur J Immunol 1996; 26: 294–9.